We would love to hear your thoughts about our site and services, please take our survey here.
BITL where is this coming from? where's your information from to form these thoughts?
If it's Ophs tweets that's very out of date and jealousy driven information.
I have no desire to defend Albert, I'd leave the group quite happily, more than likely to be kicked for being argumentative with Ophs loyal following who can't have a thought without him, I know all I need to know, I know my personal targets for selling some, and waiting for the endgame.
He doesn't give advice, if you are referring to the TA group he set up apparently it was shuttered about 3 months ago. Personally I agree that TA is playing with crayons, but it's self fulfilling, and risky for a stock like this.
Nope, I'll deny that, do you have evidence of such a thing being said? I certainly don't recall it, maybe there was some context that made me see it in a different way?
Did he? when? where? I doubt many if any did.
There's very little, if any, charting, have seen one chart in months.
There is no collusion, let's all buy/sell now, not even a hint of it, i'd argue that 90%+ of the members and probably the 90% of the 16% is held by LTHs.
The group is actively internally talking down the rampy frothy stuff on twitter, it's not necessary, most of it is guesswork or hopium, Myles's recent post of expecting something in days or weeks, was derided. If he knows something great, if not then he, like all of us, knows it works, it'll happen when it happens, we can't influence when. The spike in Oct for the 'event that never happened' is interesting, never really seen a defence of it, I call it more hopium.
It took too long for his true colours to be seen, obvious to some but the alleged technical knowledge was clouding judgements in my opinion, he had a little cult following, that's improving as his current behaviour continues on twitter etc.
nlgb there might be a similar scale here with some of it held in both groups. but honestly, reading the posts here on a daily basis, would you want this group to talk to as? you've got hurst and sujood the simpleton twins. you've got wyn, 50% of the posts here are taking the **** out of those three.
then you've got the the plain nasty, oph, the handwringing and confused touk.
honestly **** up and brewery comes to mind.
oh and newbie avct, that's bs too, lots of discussion, generally interesting and, shock horror, generally on topic. competition has been considered.
honestly if we wanted to have a meeting with people from this group who would it be? i can think of no-one, oph might have the technical knowledge but doesn't know how to talk to people. as a ceo i'd look here and see what the quality of conversation is and then i'd suddenly be too busy to host a session.
get the house in order, but there are zero tools for that, and then it might work.
NFT, i'm not sure if it is not normally treated with Dox, if it is (and some STS are) then it can only be treated for a really short period of time.
And they are still able to remain on treatment.
You've been patient?
Up until a few months ago he struggled with getting some of the details right
No FAP until they settle and start to grow a protective stroma etc.
As for the shrinking tumour problem, it's a surface to volume ratio problem, When very large there is much more volume per unit of surface area, and the volume is where growth comes from and nutrients are taken up from the blood supply etc. So as you shrink it and the surface area reduces the absolute volume reduces quicker, so there's less and less for the tumour to work with. I don't see it being a problem.
Not a medical opinion, just an engineer doing some sums.
Crypto given that formal offers are generally preceded by informal offers that could easily be rebuffed then we won't have heard much.
Rorke, you know full well that the extension of the trials was to do with it performing such that there was no sign of the mtd and has nothing to do with the patents. So what's your aim here?
That F for that he's gone again, and with his usual plethora of insults and put downs.
Did you forget the non dilutitive comment.
You'll obviously do P2 before P3, and so if P2 shows efficacy in a small group then because this is a known drug they would allow it to be used live. If it were not a known drug they'd want P3 which is many more patients to understand longer term consequences.
They may choose to shorten P2 if the results are good enough. Orphan programmes may allow for this.
Additionally for some STS dox is a known treatment but can only be used in a limited number of doses.
Alan has said that ph2 is pivotal and enough to start usage outside of trials. They may be a ph3 in parallel with usage.
Robin, if the jam was already here the case for investment is gone as the growth will have happened. Jam tomorrow = potential for growth, Jam in the jar = growth has occurred, by which point you are too late.
But it's Jim Cramer, a counter indicator to himself.
Is there even a physical location? I don't think there is.